CSF sub-study A CSF sub-study is being conducted in 15 countries as part of evoke and evoke+ to explore the effect of semaglutide on CSF biomarkers, including markers of AD, neuroinflammation, neurodegeneration, BBB integrity, oxidative stress, synaptic integrity, and vascular integrity (Table 3)
10.1016/j.genhosppsych.2025.03.012 252 LatifiS.TamayolA.HabibeyR.SabzevariR.KahnC.GenyD.et al
According to a retrospective review comparing amphetamine-derived phentermine with phentermine-topiramate, phentermine and phentermine-topiramate in addition to diet and exercise in post-RYGB and LAGB patients induced weight loss of 6.35 kg (12.8% excess weight loss) and 3.81 kg (12.9% EWL) within 90 days, respectively [14]
GLP-1, Glucose Control, and Insulin Sensitivity One of butyrate's most promising metabolic effects involves healthy blood sugar regulation